ARCA BIOPHARMA ANNOUNCES SUBMISSION OF PATENT APPLICATON TO U.S. PATENT AND TRADEMARK OFFICE COVERING TREATMENT OF ATRIAL FIBRILLATION IN PATIENTS WITH HEART FAILURE